Cite

HARVARD Citation

    Hinderer, C. et al. (2020). Adeno‐associated virus serotype 1‐based gene therapy for FTD caused by GRN mutations. Annals of clinical and translational neurology. 7 (10), pp. 1843-1853. [Online]. 
  
Back to record